Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study

BACKGROUND: Hypoxic-ischaemic encephalopathy is associated with development of cerebral palsy and cognitive disability later in life and is therefore one of the fundamental problems in perinatal medicine. The xanthine-oxidase inhibitor allopurinol reduces the formation of free radicals, thereby limi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kaandorp, Joepe J, Benders, Manon JNL, Rademaker, Carin MA, Torrance, Helen L, Oudijk, Martijn A, de Haan, Timo R, Bloemenkamp, Kitty WM, Rijken, Monique, van Pampus, Maria G, Bos, Arie F, Porath, Martina M, Oetomo, Sidarto Bambang, Willekes, Christine, Gavilanes, AW Danilo, Wouters, Maurice GAJ, van Elburg, Ruurd M, Huisjes, Anjoke JM, Bakker, Saskia CMJER, van Meir, Claudia A, von Lindern, Jeannette, Boon, Janine, de Boer, Inge P, Rijnders, Robbert JP, Jacobs, Corrie JWFM, Uiterwaal, Cuno SPM, Mol, Ben Willem J, Visser, Gerard HA, van Bel, Frank, Derks, Jan B
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2010
נושאים:
Study protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834613/
https://ncbi.nlm.nih.gov/pubmed/20167117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2393-10-8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים